Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life ...

The Human Domainome 1—the largest library of human protein variants—reveals the cause of certain genetic disorders, paving ...

A robust and efficient protein biomarker development pipeline helps scientists overcome common challenges associated with ...

The HealthWell Foundation®, a nationally recognized independent non-profit organization that offers a financial lifeline to underinsured Americans who struggle to afford critical medical treatments, ...

Biomarkers Market , valued at US$54.8 billion in 2023, is forecasted to grow at a robust CAGR of 10.2%, reaching US$57.7 ...

This study provides valuable findings on the role of site-specific DNA methylation changes during spermatogenesis and their contribution to paternal epigenetic inheritance. The study proposes that ...

Beyond its role in the initiation of digestion, the oral microbiome appears to be key to maintaining both oral and systemic ...

Third generation generic ELISA kit (Cygnus Technologies, Southport, NC, USA) was used for host cell protein (HCP) analysis. Table 1. Resin information. Proteins utilized in this study, detailed in ...

PRISM BioLab is collaborating on new PPI targets with global and Japanese pharmaceutical companies. PepMetics® targeting CBP/beta-catenin PPIs licensed to Eisai Co., Ltd. and Ohara Pharmaceu tical Co.

Elix, Inc. (CEO: Shinya Yuki / HQ: Tokyo, hereinafter "Elix"), an AI drug discovery company with the mission of "Rethinking Drug Discovery", today announced that it has entered into a drug discovery ...